Announcing a New Partnership
Dermatologic Therapy is part of a partnership between Wiley and Hindawi and is now fully open access. Dermatologic Therapy will remain a Wiley title but will be published and hosted by Hindawi and will benefit from Hindawi’s experience and expertise in publishing open access titles. Dermatologic Therapy will continue to undergo a rigorous peer review process ensuring that quality remains high. Manuscripts published after January 1, 2023 are published as open access articles, making them immediately free to read, download and share. Authors or their funder will be required to pay an Article Publication Charge upon acceptance. For further information, please click here.
COVID-19 papers
Click here for a full collection of COVID-19 content published in Dermatologic Therapy. All papers in the collection can be accessed free of charge.
Articles
Correction to “Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis”
- 5 December 2022
A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib
- 10 November 2022
A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma
- 10 November 2022
High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts
- 8 November 2022
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Moisturization and skin barrier function
- 43-48
- 21 January 2004
Consensus of Chinese experts on protection of skin and mucous membrane barrier for health‐care workers fighting against coronavirus disease 2019
- 13 March 2020
COVID-19 and economy
- 26 March 2020
Recent issues
Sign up for email alerts
Tools
Publishing Open Access? Your fees may be covered
